← FDA Drug Approvals (Drugs@FDA)
BIVALIRUDIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2017-07-06
Drug application
- FDA Application #
ANDA204876- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BIVALIRUDIN
- Generic name
- Bivalirudin
- Active ingredients
- BIVALIRUDIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2017-07-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown